Congratulations! You now have unlimited access to all articles from The Translational Scientist.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to Solutions/product profiles
digital magazine subscription
Carlo Medici
Carlo Medici is chief executive officer of Alzeca Biosciences, Houston, USA, a company developing novel advanced imaging agents for the early diagnosis of neurodegenerative diseases, including Alzheimer’s disease.